Concepedia

Christoph Klade

CK

Statistics

Publications

35

Citations

2.4K

H-Index

26

Active since

2001

Affiliations

Intercell (Austria)(Current)

Medical University of Vienna

AOP Orphan (Austria)

Vienna Biocenter

Austrian Academy of Sciences

Christoph Klade is an author at Intercell (Austria) specializing in immunology, infectious diseases, and vaccinology.

Publications per year

2001–2024

35

Publications

35

Ropeginterferon alfa-2b versus standard therapy for polycythaemia vera (PROUD-PV and CONTINUATION-PV): a randomised, non-inferiority, phase 3 trial and its extension study

Heinz Gisslinger, Christoph Klade, Pencho Georgiev et al. · The Lancet Haematology · 2020 · 347 citations

, , +5

Identification of tumor antigens in renal cell carcinoma by serological proteome analysis

Christoph Klade, Tilman Voss, E. Krystek et al. · PROTEOMICS · 2001 · 204 citations

, , +17

Ropeginterferon alfa-2b, a novel IFNα-2b, induces high response rates with low toxicity in patients with polycythemia vera

Heinz Gisslinger, Oleh Zagrijtschuk, Veronika Buxhofer‐Ausch et al. · Blood · 2015 · 184 citations · Full text

, , +9

Identification of vaccine candidate antigens of Staphylococcus aureus by serological proteome analysis

Oresta Vytvytska, Eszter Nagy, Martin Blüggel et al. · PROTEOMICS · 2002 · 165 citations

, , +17

Therapeutic Vaccination of Chronic Hepatitis C Nonresponder Patients With the Peptide Vaccine IC41

Christoph Klade, Heiner Wedemeyer, Thomas Berg et al. · Gastroenterology · 2008 · 153 citations

, , +16

1–5 of 35